etomoxir has been researched along with 2-bromostearic acid in 1 studies
| Studies (etomoxir) | Trials (etomoxir) | Recent Studies (post-2010) (etomoxir) | Studies (2-bromostearic acid) | Trials (2-bromostearic acid) | Recent Studies (post-2010) (2-bromostearic acid) |
|---|---|---|---|---|---|
| 260 | 8 | 93 | 10 | 0 | 0 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, S; Foster, DW; McGarry, JD; Ogawa, A; Ohneda, M; Unger, RH | 1 |
1 other study(ies) available for etomoxir and 2-bromostearic acid
| Article | Year |
|---|---|
More direct evidence for a malonyl-CoA-carnitine palmitoyltransferase I interaction as a key event in pancreatic beta-cell signaling.
Topics: Animals; ATP Citrate (pro-S)-Lyase; Carnitine O-Palmitoyltransferase; Citrates; Epoxy Compounds; Glucose; Hypoglycemic Agents; In Vitro Techniques; Insulin; Insulin Secretion; Islets of Langerhans; Kinetics; Male; Malonyl Coenzyme A; Palmitates; Palmitic Acid; Palmitic Acids; Rats; Rats, Sprague-Dawley; Signal Transduction; Stearic Acids; Time Factors | 1994 |